Carl A. Laskin

Carl A. Laskin

Auto-generated profile, based on publicly available information

Carl A. Laskin

University of Toronto Toronto Ontario Canada

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2016 in Blood
Verified
Journal Article
Closed access
PDF file
LSLeslie Skeith
Leslie Skeith
MCMarc Carrier
Marc Carrier
RKRisto Kaaja
Risto Kaaja
IMIda Martinelli
Ida Martinelli
DPDavid Petroff
David Petroff
MRMarc A. Rodger
Marc A. Rodger
We performed a meta-analysis of randomized controlled trials comparing low-molecular-weight heparin (LMWH) vs no LMWH in women with inherited thrombophilia and prior late (≥10 weeks) or recurrent early (<10 weeks) pregnancy loss. Eight trials and 483 patients met our inclusion criteria. There was no significant difference in livebirth rates with the use of LMWH compared with no LMWH (relative risk, 0.81; 95% confidence interval, 0.55-1.19; P = .28), suggesting no benefit of LMWH in preventing recurrent pregnancy loss in women with inherited thrombophilia.

8 April 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SHSeunghee Hong
Seunghee Hong
RBRomain Banchereau
Romain Banchereau
BMBat-Sheva L. Maslow
Bat-Sheva L. Maslow
MGMarta M. Guerra
Marta M. Guerra
JCJacob Cardenas
Jacob Cardenas
VPVirginia Pascual
Virginia Pascual
Systemic lupus erythematosus carries an increased risk of pregnancy complications, including preeclampsia and fetal adverse outcomes. To identify the underlying molecular mechanisms, we longitudinally profiled the blood transcriptome of 92 lupus patients and 43 healthy women during pregnancy and postpartum and performed multicolor flow cytometry in a subset of them. We also profiled 25 healthy women undergoing assisted reproductive technology to monitor transcriptional changes around embryo implantation. Sustained down-regulation of multiple immune signatures, including interferon and plasma cells, was observed during healthy pregnancy. These changes appeared early after embryo implantation and were mirrored in uncomplicated lupus pregnancies. Patients with preeclampsia displayed early up-regulation of neutrophil signatures that correlated with expansion of immature neutrophils. Lupus pregnancies with fetal complications carried the highest interferon and plasma cell signatures as well as activated CD4+ T cell counts. Thus, blood immunomonitoring reveals that both healthy and uncomplicated lupus pregnancies exhibit early and sustained transcriptional modulation of lupus-related signatures, and a lack thereof associates with adverse outcomes. Graphical Abstract

1 April 2016 in Fertility and Sterility
Verified
Journal Article
Closed access
NDNatalie Dayan
Natalie Dayan
ALAndrea Lanes
Andrea Lanes
MWMark C. Walker
Mark C. Walker
KSKaren A. Spitzer
Karen A. Spitzer
CLCarl A. Laskin
Carl A. Laskin

1 April 2021 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
TDTalia Diaz
Talia Diaz
DDDaniela Dominguez
Daniela Dominguez
EJEdgar Jaeggi
Edgar Jaeggi
AKAndrea M. Knight
Andrea M. Knight
CLCarl A. Laskin
Carl A. Laskin
LHLinda T. Hiraki
Linda T. Hiraki
Objective: To evaluate the association between ethnicity and neonatal lupus erythematosus (NLE), as well as specific NLE manifestations in a large multiethnic population.Methods: We conducted a cohort study of the children (≤ 1 yr of age) seen in the NLE clinic at The Hospital for Sick Children (SickKids), between January 2011 and April 2019. The cohort was divided into European, non-European, and mixed European–non-European groups according to parent-reported child’s ethnicity (Canada Census categories). Outcomes were NLE and specific NLE manifestations (cardiac, cutaneous, cytopenias, transaminitis, and macrocephaly). The frequency of NLE and specific manifestations were compared between ethnic groups (Fisher exact test). We tested the association between ethnicity and (1) NLE risk, and (2) specific NLE manifestations with logistic regression models, including covariates for child’s sex, maternal rheumatic disease status during pregnancy, and maternal use of antimalarials during pregnancy (multiple comparisons threshold P < 0.008).Results: We included 324 children born to 270 anti-Ro antibody–positive mothers. Median age at first visit was 1.8 (IQR 1.4–2.3) months, and median follow-up time was 12 (IQR 2–24) months. The majority was non-European (48%), with 34% European, and 18% mixed European–non-European. There was no significant association between non-European ethnicity (OR 1.18, 95% CI 0.71–1.94, P = 0.51), mixed European–non-European ethnicity (OR 1.13, 95% CI 0.59–2.16, P = 0.70), and NLE risk compared with European ethnicity. We also did not find an association between ethnicity and specific NLE manifestations in univariate or multivariable-adjusted models.Conclusion: In a large multiethnic cohort, there was no association between a child’s ethnicity and NLE risk or specific NLE manifestations.

1 January 2022 in F&S Reviews
Verified
Journal Article
Closed access
GGGeneviève Genest
Geneviève Genest
WAWalaa Almasri
Walaa Almasri
SBShorooq Banjar
Shorooq Banjar
CBCoralie Beauchamp
Coralie Beauchamp
WBWilliam Buckett
William Buckett
CLCarl A. Laskin
Carl A. Laskin

29 August 2016 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
CLCarl A. Laskin
Carl A. Laskin
KSKaren A. Spitzer
Karen A. Spitzer
Given that this patient has had three early pregnancy losses, she should undergo investigations for recurrent early pregnancy loss. Pregnancy loss in the first trimester is common, regardless of age. The incidence of a first-trimester loss is estimated at 15%–30%, but it varies substantially according to age, increasing to 51% among women 41–44 years of age.1,2 This patient has at least a 15% probability of a first-trimester loss (and it may be as high as 30%).3 After one early loss, the probability of a subsequent successful pregnancy is identical with that of any woman in this age group.4